Key Takeaways
CVS Health ( CVS ) shares powered 9% higher before the bell Thursday after the pharmacy and healthcare giant's first-quarter results handily topped estimates.
Revenue grew 7% year-over-year to $94.59 billion, while adjusted earnings per share (EPS) rose more than 70% to $2.25. Each metric came in well above the analyst consensus compiled by Visible Alpha.
The company trimmed its EPS guidance range to $4.23 to $4.43, down from $4.58 to $4.83 previously. However, CVS lifted its adjusted EPS projection to $6.00 to $6.20, up from its previous range of $5.75 to $6.00.
The pharmacy chain and Aetna health insurance operator said it updated its outlook to "reflect strong performance across each of our businesses, while maintaining a cautious view for the remainder of the year in light of continued elevated cost trends and the potential for macro headwinds."
Last month, the company said it would likely meet or exceed that adjusted EPS range, and appointed a new CFO, Brian Newman.
CVS Health shares are poised for their highest open since April 2024. Entering the day, shares were up nearly 50% since the start of the year.
Read the original article on Investopedia